Antidepressants and Suicide Prevention

dc.contributor.authorGoldney, R.
dc.contributor.editorO'Connor, R.
dc.contributor.editorPlatt, S.
dc.contributor.editorGordon, J.
dc.date.issued2011
dc.description.statementofresponsibilityRobert D. Goldney
dc.description.urihttp://trove.nla.gov.au/work/38691633
dc.identifier.citationInternational Handbook of Suicide Prevention: Research, Policy and Practice, 2011 / O'Connor, R., Platt, S., Gordon, J. (ed./s), pp.457-472
dc.identifier.doi10.1002/9781119998556.ch26
dc.identifier.isbn9780470683842
dc.identifier.urihttp://hdl.handle.net/2440/68341
dc.language.isoen
dc.publisherWiley
dc.publisher.placeUnited Kingdom
dc.rightsCopyright © 2011 John Wiley & Sons, Ltd.
dc.source.urihttps://doi.org/10.1002/9781119998556.ch26
dc.subjectantidepressants and suicide prevention
dc.subjectnewer selective serotonin re-uptake inhibitors (SSRIs) - suicide in the vulnerable
dc.subjectsuicide, and depression - antidepressant measures, reducing likelihood of suicide
dc.subjectclinical intervention follow-up
dc.subjectpharmaco-epidemiological approach - data from antidepressant sales, national suicide statistics employed, by Isacsson
dc.subjectantidepressant drug treatment - and attempted suicide, children and adolescents
dc.subjectnumber needed to harm (NNH) - balanced with number needed to treat (NNT), for recovery
dc.subjectevaluating risk of not treating, and balancing - risks and benefits of treatment
dc.titleAntidepressants and Suicide Prevention
dc.typeBook chapter
pubs.publication-statusPublished

Files